维普中文期刊产品整合服务
437篇 您的检索式:作者名="HARTMANN P"
    题名 作者 年代 出处 被引量
1Diagnosis of focal liver lesions with deep learning-based multichannel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging显示文摘BACKGROUND The nature of input data is an essential factor when training neural networks.Research concerning magnetic resonance imaging(MRI)-based diagnosis of liver tumors using deep learning has been rapidly advancing.Still,evidence to support the utilization of multi-dimensional and multi-parametric image data is lacking.Due to higher information content,three-dimensional input should presumably result in higher classification precision.Also,the differentiation between focal liver lesions(FLLs)can only be plausible with simultaneous analysis of multisequence MRI images.AIM To compare diagnostic efficiency of two-dimensional(2D)and three-dimensional(3D)-densely connected convolutional neural networks(DenseNet)for FLLs on multi-sequence MRI.METHODS We retrospectively collected T2-weighted,gadoxetate disodium-enhanced arterial phase,portal venous phase,and hepatobiliary phase MRI scans from patients with focal nodular hyperplasia(FNH),hepatocellular carcinomas(HCC)or liver metastases(MET).Our search identified 71 FNH,69 HCC and 76 MET.After volume registration,the same three most representative axial slices from all sequences were combined into four-channel images to train the 2D-DenseNet264 network.Identical bounding boxes were selected on all scans and stacked into 4D volumes to train the 3D-DenseNet264 model.The test set consisted of 10-10-10 tumors.The performance of the models was compared using area under the receiver operating characteristic curve(AUROC),specificity,sensitivity,positive predictive values(PPV),negative predictive values(NPV),and f1 scores.RESULTS The average AUC value of the 2D model(0.98)was slightly higher than that of the 3D model(0.94).Mean PPV,sensitivity,NPV,specificity and f1 scores(0.94,0.93,0.97,0.97,and 0.93)of the 2D model were also superior to metrics of the 3D model(0.84,0.83,0.92,0.92,and 0.83).The classification metrics of FNH were 0.91,1.00,1.00,0.95,and 0.95 using the 2D and 0.90,0.90,0.95,0.95,and 0.90 using the 3D models.The 2D and 3D networks'performance in the diagnosis of HCC were 1.00,0.80,0.91,1.00,and 0.89 and 0.88,0.70,0.86,0.95,and 0.78,respectively;while the evaluation of MET lesions resulted in 0.91,1.00,1.00,0.95,and 0.95 and 0.75,0.90,0.94,0.85,and 0.82 using the 2D and 3D networks,respectively.CONCLUSION Both 2D and 3D-DenseNets can differentiate FNH,HCC and MET with good accuracy when trained on hepatocyte-specific contrast-enhanced multi-sequence MRI volumes.Róbert Stollmayer Bettina K Budai Ambrus Tóth IldikóKalina Erika Hartmann Péter Szoldán Viktor Bérczi Pál Maurovich-Horvat Pál N Kaposi 2021World Journal of Gastroenterology2021,27,35:6
2Protective action of glutamine in rats with severe acute liver failure显示文摘BACKGROUND Severe acute liver failure(SALF) is a rare, but high-mortality, rapidly evolving syndrome that leads to hepatocyte degeneration with impaired liver function.Thioacetamide(TAA) is a known xenobiotic, which promotes the increase of the formation of reactive oxygen species. Erythroid 2-related factor 2(Nrf2) activates the antioxidant protection of cells. Studies have evidenced the involvement of inflammatory mediators in conditions of oxidative stress.AIM To evaluate the antioxidant effects of glutamine on Nrf2 activation and NFκBmediated inflammation in rats with TAA-induced IHAG.METHODS Male Wistar rats(n = 28) were divided into four groups: control,control+glutamine, TAA, and TAA + glutamine. Two TAA doses(400 mg/kg)were administered intraperitoneally, 8 h apart. Glutamine(25 mg/kg) was administered at 30 min, 24 h, and 36 h. At 48 h, blood was collected for liver integrity analysis [aspartate aminotransferase(AST), alanine aminotransferase(ALT), and alkaline phosphatase(ALP)]. The liver was harvested for histology and assessment of oxidative stress [thiobarbituric acid-reactive substances(TBARS), catalase(CAT), glutathione peroxidase(GPx), glutathione S-transferase(GST), glutathione(GSH), Nrf2, Kelch-like ECH-associated protein 1(Keap1),NADPH quinone oxidoreductase1(NQO1), superoxide dismutase(SOD)] and inflammatory process.RESULTS TAA caused disruption of the hepatic parenchyma, with inflammatoryinfiltration, massive necrosis, and ballooning degeneration. Glutamine mitigated this tissue damage, with visible regeneration of hepatic parenchyma; decreased TBARS(P < 0.001), GSH(P < 0.01), IL-1β, IL6, and TNFα levels(P <0.01) in hepatic tissue; and decreased blood levels of AST, ALT, and ALP(P <0.05). In addition, CAT, GPx, and GST activities were restored in the glutamine group(P<0.01, P <0.01, and P <0.001, respectively vs TAA alone). Glutamine increased expression of Nrf2(P < 0.05), NQO1, and SOD(P < 0.01), as well as levels of IL-10(P <0.001), while decreasing expression of Keap1, TLR4, NFκB(P < 0.001), COX-2 and iNOS,(P < 0.01), and reducing NO_2 and NO_3 levels(P < 0.05).CONCLUSION In the TAA experimental model of IHAG, glutamine activated the Nrf2 pathway,thus promoting antioxidant protection, and blunted the NFκB-mediated pathway, reducing inflammation.Elizangela G Schemitt Renata M Hartmann Josieli R Colares Francielli Licks Jéferson O Salvi Cláudio A Marroni Norma P Marroni 2019World Journal of Hepatology2019,11,3:5
3Compared efficacy of preservation solutions on the outcome of liver transplantation:Meta-analysis显示文摘AIM To compare the effects of the four most commonly used preservation solutions on the outcome of liver transplantations.METHODS A systematic literature search was performed using MEDLINE, Scopus, EMBASE and the Cochrane Library databases up to January 31^(st), 2017. The inclusion criteria were comparative, randomized controlled trials(RCTs) for deceased donor liver(DDL) allografts with adult and pediatric donors using the gold standard University of Wisconsin(UW) solution or histidinetryptophan-ketoglutarate(HTK), Celsior(CS) and Institut Georges Lopez(IGL-1) solutions. Fifteen RCTs(1830 livers) were included; the primary outcomes were primary non-function(PNF) and one-year posttransplant graft survival(OGS-1). RESULTS All trials were homogenous with respect to donor and recipient characteristics. There was no statistical difference in the incidence of PNF with the use of UW, HTK, CS and IGL-1(RR = 0.02, 95%CI: 0.01-0.03, P = 0.356). Comparing OGS-1 also failed to reveal any difference between UW, HTK, CS and IGL-1(RR = 0.80, 95%CI: 0.80-0.80, P = 0.369). Two trials demonstrated higher PNF levels for UW in comparison with the HTK group, and individual studies described higher rates of biliary complications where HTK and CS were used compared to the UW and IGL-1 solutions. However, the meta-analysis of the data did not prove a statistically significant difference: the UW, CS, HTK and IGL-1 solutions were associated with nearly equivalent outcomes.CONCLUSION Alternative solutions for UW yield the same degree of safety and effectiveness for the preservation of DDLs, but further well-designed clinical trials are warranted.Agnes Lilla Szilágyi Péter Mátrai Péter Hegyi Eszter Tuboly Daniella Pécz András Garami Margit Solymár Erika Pétervári Márta Balaskó Gábor Veres László Czopf Bastian Wobbe Dorottya Szabó Juliane Wagner Petra Hartmann 2018World Journal of Gastroenterology2018,24,16:5
4Detection of pathogenic Yersinia enterocolitica in meat using real-tinm PCR显示文摘FREDRIKSSON-AHOMAA M HARTMANN B SCHEU P 2007Journal of Consumer Protection and Food Safety2007,2,2:1
5Calibration a structured light stripe system: a novel approach 显示文摘Huynh D Q Owens R A Hartmann P E 1999lnt J Comp Vis(S0920-5691)1999,33,1:1
6A rechargeable room-temperature sodium superoxide (NaOz) battery显示文摘Hartmann P Bender C L Vracar M 2013Nature Materials2013,12,3:1
7Z-path SAW RFID tag显示文摘Harma S Plessky V P Hartmann C S 2008IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control2008,55,1:1
8The impact of crop growth sub-model choice on simulated water and nitrogen balances 显示文摘Eckart Priesack Sebastian Gayler Hans P Hartmann 2006Nutrient Cycling in Agroecosystems2006,75,7:1
9Primary ovarian tumors显示文摘Davis K P Hartmann L K Keeney G L 1996Gynecol Oncol1996,61,2:1
10A field technique for evaluating physical condition of deer显示文摘Kistner T P Trainer C E Hartmann N A 1980Wildl Soc Bull1980,8,1:1
11Neutron Radiography as Visu- alization and Quantification method for Conservation Measures of Wood Firmness Enhancement显示文摘Lehmann E Hartmann S Wyer P 2005Nuclear Instruments and Meth- ods in Physics Research A2005,542,:1
12Expression of functional Fas ligand in chofiocarcinoma 显示文摘Hanner A Hartmann M Sedlmayr P 2002Am J Reprod Immunol2002,48,4:1
13Asset market linkages in crisis periods 显示文摘HARTMANN P STRAETMANS S DE VRIES C G 2004Review of Economics and Statistics2004,86,1:1
14Four- month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD显示文摘Henriksen DB Alexandersen P Hartmann 13 2009Bone2009,45,5:1
15Perovskite manganites: potential materials for magnetic cooling at or near room temperature 显示文摘Xu Y Meier M Das P Koblischka M R Hartmann U 2002Crystal Engineering2002,5,:1
16Development of 207Pb,208Pb and 209Bi target wheels in the synthesis of 107Ns,108Hs and 109Mt显示文摘Folger H Hartmann W Heβberger F P 1993Nuclear Instruments and Methods in Physics Research A1993,334,1:1
17Deficiency of in- testinal mucin-2 ameliorates experimental alcoholic liver disease in mice显示文摘Hartmann P Chen P Wang ILl 2013Hepatology2013,58,:1
18Four-month treatment with GLP-2 significantly increases hip BMD: random- ized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD显示文摘Henriksen DB Alexandersen P Hartmann B 2009Bone2009,45,5:1
19Immunological defense mechanisms in tuberculosis and MAC-Infection显示文摘Hartmann P Plum G 1999Diagn Microbial Infect Dis1999,34,7:1
20Hematoma growth and outcome in treated neur- ocfitical care patients with intracerebral hemorrhage relat- ed to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates显示文摘HUTTNER H B SCHELLINGER P D HARTMANN M 2006Stroke2006,37,:1
返回顶部 每页显示:
共22页 首页 上一页 第1页 下一页 末页 /22 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费